Table 2.
Fecal concentrations of total UBA and total and relative fecal concentrations of primary and secondary UBA at baseline (D0), end of tylosin treatment (D7) and 1 week after tylosin discontinuation (D14).
| Total UBA Concentration (μg/mg) | Primary UBA Concentration (μg/mg) | Primary UBA Percentage of Total UBA | Secondary UBA Concentration (μg/mg) |
Secondary UBA Percentage of Total UBA | |
|---|---|---|---|---|---|
| Control (D0) | 2.65 (1.88–4.27) | 0.16 (0.05–0.72) | 6.1 (1.7–19.8) | 2.51 (0.52–4.00) | 93.4 (80–2-98.3) |
| Control (D7) | 1.79 (1.01–5.03) | 1.40 (0.61–4.41) * | 75.8 (60.7–87.5) * | 0.42 (0.33–0.63) * | 24.2 (12.5–39.3) * |
| Control (D14) | 3.38 (1.34–7.31) | 0.24 (0.07–3.45) | 6.9 (1.3–88.9) | 2.41 (0.43–7.07) | 93.1 (11.1–98.7) |
| Enema FMT (D0) | 2.46 (1.18–5.75) | 0.15 (0.03–0.49) | 4.9 (0.5–31.8) | 2.20 (0.80–5.72) | 95.1 (68.2–99.4) |
| Enema FMT (D7) | 2.02 (1.37–4.01) | 1.56 (1.09–3.37) * | 78.8 (70.1–85.2) * | 0.46 (0.28–0.81) * | 21.2 (14.8–29.9) * |
| Enema FMT (D14) | 4.00 (1.26–4.39) | 0.16 (0.03–0.88) | 5.9 (1.6–23.4) | 3.34 (1.23–4.32) | 94.1 (76.6–98.4) |
| Oral FMT (D0) | 3.15 (1.09–4.01) | 0.11 (0.04–0.79) | 3.1 (1.7–20.1) | 3.02 (0.97–3.92) | 96.9 (79.9–98.9) |
| Oral FMT (D7) | 2.14 (1.44–3.61) | 1.69 (1.08–2.70) * | 74.9 (71.1–84.3) * | 0.53 (0.35–0.91)* | 25.1 (15.7–28.9) * |
| Oral FMT (D14) | 3.33 (2.14–4.81) | 0.16 (0.06–0.35) | 3.7 (1.5–16.6) | 3.19 (1.79–4.70) | 96.3 (83.4–98.5) |
All data expressed as median (minimum–maximum). D0 = baseline, D7 = last day of tylosin treatment, D14 = 7 days after discontinuation of tylosin. * Statistically different from D0 in same group.